Literature DB >> 6850538

Acral lentiginous melanoma. A clinicopathologic study of 36 patients.

R R Paladugu, C D Winberg, R H Yonemoto.   

Abstract

Acral lentiginous melanoma (ALM) is a distinct variant of malignant melanoma with a predilection for the soles, palms, and nail beds. This melanoma has characteristic histologic features, and its biologic behavior is similar to that of nodular melanoma. It occurs predominantly in the sixth, seventh, and eighth decades of life, with a peak incidence in the seventh decade for males and in the sixth decade for females. Diagnosis of ALM during the radial growth phase is often difficult, and it may not be recognized initially, but treatment in this phase offers an excellent prognosis. There is a high incidence of regressive changes and desmoplasia in ALM; these changes, together with the anatomic peculiarities of nail beds, palms, and soles as compared with other skin areas, make it difficult to determine the Clark's level and to measure the depth of invasion. Wide local excision with lymph node dissection is recommended for subungual melanomas measuring more than 1.00 mm and for lesions showing severe regression. Volar melanomas less than 1.00 mm deep and those in the radial growth phase with minimal invasion require only wide local excision. Amputation of digits and lymph node dissection are recommended for subungual melanomas, if the melanomas exhibit the vertical growth phase. If there is only radial growth without regressive changes, wide local excision is adequate. Patients with metastasis to lymph nodes at the time of diagnosis usually have shorter survival times than do those without lymph node involvement (P = 0.027).

Entities:  

Mesh:

Year:  1983        PMID: 6850538     DOI: 10.1002/1097-0142(19830701)52:1<161::aid-cncr2820520129>3.0.co;2-r

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Subungal melanoma.

Authors:  W J Campbell; C V Harper; J M Alderdice; W G Humphreys
Journal:  Ir J Med Sci       Date:  1990-05       Impact factor: 1.568

2.  [Operative therapy of acral melanomas].

Authors:  M Möhrle; V Lichte; H Breuninger
Journal:  Hautarzt       Date:  2011-05       Impact factor: 0.751

3.  Analysis of recurrence patterns in acral versus nonacral melanoma: should histologic subtype influence treatment guidelines?

Authors:  Priyanka V Gumaste; Nathaniel H Fleming; Ines Silva; Richard L Shapiro; Russell S Berman; Judy Zhong; Iman Osman; Jennifer A Stein
Journal:  J Natl Compr Canc Netw       Date:  2014-12       Impact factor: 11.908

4.  Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005.

Authors:  Porcia T Bradford; Alisa M Goldstein; Mary L McMaster; Margaret A Tucker
Journal:  Arch Dermatol       Date:  2009-04

5.  Acral lentiginous melanoma in the Turkish population and a new dermoscopic clue for the diagnosis.

Authors:  Fezal Ozdemir; Micol A Errico; Banu Yaman; Isil Karaarslan
Journal:  Dermatol Pract Concept       Date:  2018-04-30

6.  Acral lentiginous melanoma in situ: a diagnostic and management challenge.

Authors:  Hyun Sun Park; Kwang Hyun Cho
Journal:  Cancers (Basel)       Date:  2010-04-20       Impact factor: 6.639

7.  Acral Melanoma in Chinese: A Clinicopathological and Prognostic Study of 142 cases.

Authors:  Jiaojie Lv; Bo Dai; Yunyi Kong; Xuxia Shen; Jincheng Kong
Journal:  Sci Rep       Date:  2016-08-22       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.